{
  "$schema": "https://themachinepress.com/schemas/story-v1.schema.json",
  "schema_version": "1.0.0",
  "document_type": "machine_press_story",
  "story": {
    "story_id": "mp-2026-07-15-011",
    "source_story_id": "tmp-story-nnos-glioblastoma-drug-resistance",
    "edition_id": "mp-2026-07-15-morning-0006",
    "edition_url": "https://themachinepress.com/edition/2026-07-15",
    "position": 11,
    "story_type": "dispatch",
    "section": "research",
    "editorial_classification": "editorial",
    "headline": "A Brain-Cancer Resistance Route Meets a New Inhibitor",
    "slug": "a-brain-cancer-resistance-route-meets-a-new-inhibitor",
    "dek": "Cell experiments found that blocking neuronal nitric oxide synthase could resensitize temozolomide-resistant glioblastoma models.",
    "summary": "Cell experiments found that blocking neuronal nitric oxide synthase could resensitize temozolomide-resistant glioblastoma models.",
    "body_text": "Hebrew University researchers tested a neuronal nitric oxide synthase inhibitor against glioblastoma cells that had become resistant to temozolomide. The experimental approach targeted a survival pathway associated with drug resistance and restored treatment sensitivity in the reported cell models. The result identifies a candidate combination strategy for further study. It remains preclinical work in cells and does not show safety or benefit in patients.",
    "why_it_matters": "Cell experiments found that blocking neuronal nitric oxide synthase could resensitize temozolomide-resistant glioblastoma models.",
    "limitations": [
      "It remains preclinical work in cells and does not show safety or benefit in patients."
    ],
    "importance": 8,
    "canonical_url": "https://themachinepress.com/story/mp-2026-07-15-011/a-brain-cancer-resistance-route-meets-a-new-inhibitor",
    "json_url": "https://themachinepress.com/story/mp-2026-07-15-011.json",
    "first_published_at": "2026-07-15T09:00:00.000-04:00",
    "modified_at": "2026-07-15T09:00:00.000-04:00",
    "content_status": "new",
    "is_carryover": false,
    "carryover_reason": null,
    "key_claims": [
      {
        "claim_id": "claim-mp-2026-07-15-011-001",
        "text": "Cell experiments found that blocking neuronal nitric oxide synthase could resensitize temozolomide-resistant glioblastoma models.",
        "source_ids": [
          "source-2026-07-15-011"
        ],
        "qualification": "It remains preclinical work in cells and does not show safety or benefit in patients."
      }
    ],
    "source_ids": [
      "source-2026-07-15-011"
    ],
    "tags": [
      "glioblastoma",
      "drug resistance",
      "temozolomide",
      "preclinical"
    ],
    "image_url": null,
    "corrections": []
  },
  "sources": [
    {
      "source_id": "source-2026-07-15-011",
      "title": "Hebrew University via EurekAlert: Experimental approach to drug-resistant brain cancer",
      "publisher": "Hebrew University via EurekAlert",
      "url": "https://www.eurekalert.org/news-releases/1135454",
      "canonical_url": "https://www.eurekalert.org/news-releases/1135454",
      "source_type": "official_announcement",
      "is_primary_source": true,
      "published_at": "2026-07-08T20:00:00.000-04:00",
      "accessed_at": "2026-07-15T08:39:00.895-04:00",
      "supports_claim_ids": [
        "claim-mp-2026-07-15-011-001"
      ]
    }
  ],
  "corrections": [],
  "publisher": {
    "name": "The Machine Press",
    "url": "https://themachinepress.com",
    "description": "A daily newspaper for the age of artificial intelligence."
  },
  "cite_this_report": {
    "title": "A Brain-Cancer Resistance Route Meets a New Inhibitor",
    "publisher": "The Machine Press",
    "published_at": "2026-07-15T09:00:00.000-04:00",
    "canonical_url": "https://themachinepress.com/story/mp-2026-07-15-011/a-brain-cancer-resistance-route-meets-a-new-inhibitor"
  }
}